Events

Gelflex Sterile Eye Wash Normal Saline 10mL Ampoule 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Covidien Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2014-RN-01130-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2014-11-07
  • 사례 국가
    Australia
  • 사례 출처
    DHTGA
  • 사례 출처 URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2014-RN-01130-1
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Covidien pty ltd (covidien), following advice from the therapeutic goods administration and the manufacturer marck biosciences ltd (now known as amanta healthcare ltd) that batch number 1t2324002 of the below product has failed the test for sterility, is recalling this batch at the retail level. please note that there have been no adverse events reported regarding this sterility test failure.
  • 조치
    Covidien is requesting the customers to identify and quarantine the affected stock. Covidien will arrange for shipment pickup from the distribution centre and will provide credit note for the returned stock. This action has been closed-out on 05/12/2016.

Device

Gelflex Sterile Eye Wash Normal Saline 10mL Ampoule
  • 모델명 / 제조번호(시리얼번호)
    Gelflex Sterile Eye Wash Normal Saline 10mL AmpouleProduct code: 8200Batch number: 1T2324002Expiry Date: December 2017ARTG Number: 151536
  • Manufacturer
    Covidien Pty Ltd

Manufacturer

Covidien Pty Ltd
  • 제조사 모회사 (2017)
    Medtronic plc
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    DHTGA